Hendrik Grootaert
Papers
1
Total Citations
17
H-Index
1
About
Hendrik Grootaert is a leading figure in clinical glycobiology, with his research centered on the role of immunoglobulin G (IgG) glycosylation in chronic inflammatory and autoimmune diseases. His major contribution lies in developing a groundbreaking, simplified clinical chemistry procedure using Endoglycosidase S to directly assess serum IgG undergalactosylation—a hallmark of conditions like rheumatoid arthritis, Crohn’s disease, lupus, and steatohepatitis. This innovation, detailed in his 2018 paper (17 citations), replaces complex, multi-step mass spectrometry methods with a streamlined, enzyme-based assay, dramatically improving accessibility for routine diagnostics. Grootaert’s work has profound implications for monitoring disease activity and therapeutic responses, bridging a critical gap between fundamental glycobiology and clinical practice. By enabling rapid, cost-effective screening, he has paved the way for personalized treatment strategies in chronic inflammation. His achievements underscore a career dedicated to translating molecular insights into tangible tools for patient care, making him a pivotal researcher for students and clinicians alike.
Research Focus
Key Achievements
Top Papers
- 1